Publicacións en colaboración con investigadores/as de Oregon Health & Science University (5)

2024

  1. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

    Blood, Vol. 143, Núm. 17, pp. 1713-1725

  2. Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

    Journal of Clinical Oncology, Vol. 42, Núm. 22, pp. 2702-2712

2022

  1. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

    New England Journal of Medicine, Vol. 386, Núm. 7, pp. 629-639

  2. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

    Nature Medicine, Vol. 28, Núm. 2, pp. 325-332

2016

  1. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

    Leukemia, Vol. 30, Núm. 9, pp. 1844-1852